BXMT · XBRL financial data

Blackstone Mortgage Trust financial statements, every quarter

The same tables from 12 filings, lined up. Matched by XBRL tag: renamed lines keep their history.

How these numbers work

Every number comes from the company's XBRL financial data filed with the SEC, and each one links to its filing.
Lines are matched by XBRL tag, so a line renamed between filings keeps its history.
* marks a quarter worked out from the filing totals: the 10-K year minus the first three quarters, or a year-to-date total minus the earlier one. Fourth-quarter earnings per share is fourth-quarter net income over the fourth-quarter weighted shares.
0 means a filing states zero; a dash (—) means no filing states that number.
“year only” means the 10-K gives the full year but not the quarters needed to work out the fourth. A worked-out quarter of revenue, cost of revenue or operating cash flow more than twice the company's largest quarter of the two years before is shown this way too.
Gross profit is shown as the company reports it; a worked-out quarter must equal revenue less cost of revenue for that quarter, or it is a dash.
Operating income can be above gross profit when the company books other operating income between the two, shown on its own line.
Shares outstanding come from each filing's cover page, as of the date printed there.
Quarters are fiscal: Q2 FY27 is the second quarter of the company's fiscal 2027.

Income statement

Fiscal quarters (BXMT's year ends in late December)

In millions of dollars	Q4 FY23Dec 31, 2023	Q1 FY24Mar 31, 2024	Q2 FY24Jun 30, 2024	Q3 FY24Sep 30, 2024	Q4 FY24Dec 31, 2024	Q1 FY25Mar 31, 2025	Q2 FY25Jun 30, 2025	Q3 FY25Sep 30, 2025	Q4 FY25Dec 31, 2025	Q1 FY26Mar 31, 2026	Q2 FY26Jun 30, 2026	Q3 FY26Sep 30, 2026
General and administrative	13*	14	14	13	13*	13	14	13	13*	14	15	13
Other operating income (expense)	—	—	—	—	—	0	0	0	—	0	0	0
Interest expense	351*	344	—	—	—	—	—	—	—	—	—	—
Income tax expense (benefit)	1*	1	1	1	(0)*	1	1	2	1*	1	3	1
Net income (loss)	(2)*	(124)	(61)	(56)	37*	(0)	7	63	40*	(6)	(81)	(327)
Earnings per share, basic USD per share	(0.01)*	(0.71)	(0.35)	(0.32)	0.21*	0.00	0.04	0.37	0.24*	(0.04)	(0.48)	(1.95)
Earnings per share, diluted USD per share	(0.02)*	(0.71)	(0.35)	(0.32)	0.21*	0.00	0.04	0.37	0.24*	(0.04)	(0.48)	(1.95)
Weighted average shares, basic millions of shares	173*	174	174	174	173*	172	172	172	168*	169	169	168
Weighted average shares, diluted millions of shares	157*	174	174	174	173*	172	172	172	168*	169	169	168

Fiscal quarters (BXMT's year ends in late December)

In millions of dollars	Q4 FY23Dec 31, 2023	Q1 FY24Mar 31, 2024	Q2 FY24Jun 30, 2024	Q3 FY24Sep 30, 2024	Q4 FY24Dec 31, 2024	Q1 FY25Mar 31, 2025	Q2 FY25Jun 30, 2025	Q3 FY25Sep 30, 2025	Q4 FY25Dec 31, 2025	Q1 FY26Mar 31, 2026	Q2 FY26Jun 30, 2026	Q3 FY26Sep 30, 2026
Cash and cash equivalents	350	414	374	322	323	669	388	378	453	549	433	512
Total assets	24,036	23,266	22,637	21,443	19,802	19,957	20,584	19,700	20,003	19,630	19,404	17,460
Total liabilities	19,649	19,101	18,632	17,583	16,008	16,269	16,961	16,102	16,499	16,212	16,139	14,620
Accumulated deficit	(1,151)	(1,383)	(1,552)	(1,690)	(1,734)	(1,815)	(1,889)	(1,906)	(1,945)	(2,031)	(2,192)	(2,597)
Total stockholders' equity	4,368	4,145	3,985	3,845	3,787	3,682	3,617	3,591	3,499	3,415	3,262	2,838
Total liabilities and equity	24,036	23,266	22,637	21,443	19,802	19,957	20,584	19,700	20,003	19,630	19,404	17,460
Common shares outstanding (cover page) millions of shares	174	174	174	173	172	172	172	168	169	169	169	166

Fiscal quarters (BXMT's year ends in late December)

In millions of dollars	Q4 FY23Dec 31, 2023	Q1 FY24Mar 31, 2024	Q2 FY24Jun 30, 2024	Q3 FY24Sep 30, 2024	Q4 FY24Dec 31, 2024	Q1 FY25Mar 31, 2025	Q2 FY25Jun 30, 2025	Q3 FY25Sep 30, 2025	Q4 FY25Dec 31, 2025	Q1 FY26Mar 31, 2026	Q2 FY26Jun 30, 2026	Q3 FY26Sep 30, 2026
Net income (loss)	(2)*	(124)	(61)	(56)	37*	(0)	7	63	40*	(6)	(81)	(327)
Stock-based compensation	8*	8	8	8	8*	7	7	7	7*	7	7	7
Net cash from operating activities	110*	95	100*	87*	85*	101	57*	(18)*	136*	170	65*	(18)*
Net cash from investing activities	257*	376	488*	1,286*	1,347*	261	(492)*	833*	(242)*	221	(35)*	1,749*
Proceeds from issuing common stock	0*	—	—	—	year only	—	—	—	—	—	—	—
Share repurchases	0*	0	0*	11*	18*	32	0*	16*	62*	1	3*	36*
Dividends paid	107*	107	108*	108*	81*	81	81*	81*	80*	79	79*	79*
Net cash from financing activities	(440)*	(404)	(628)*	(1,426)*	(1,424)*	(18)	147*	(823)*	180*	(293)	(146)*	(1,650)*
Net change in cash	—	67	—	—	—	343	—	—	—	—	—	—

SIC 6798 and related industry codes, similar size. Each row is the latest quarter reported.

How peers are chosen

SIC 6798 and related industry codes with public float (or, where float is missing, quarterly revenue) between 0.2x and 5x the company's.
Each row is the latest quarter the company has reported, named in the Quarter column; when that filing is a 10-K, it is the fourth quarter, never the full year.
* marks a quarter worked out from the filing totals: for a 10-Q, the year-to-date total less the earlier one.
A cell reading “not reported” means the filings give no figure for that quarter alone.

Company	Cash ($M)	Revenue, quarter ($M)	Operating cash flow, quarter ($M)	Shares outstanding	Quarter
Blackstone Mortgage Trust	512	not reported	(18)*	166.0M	Q3 FY26 10-QSep 30, 2026
Highwoods Properties	279	218	not reported	110.3M	Q3 FY26 10-QSep 30, 2026
HA Sustainable Infrastructure Capital	250	121	68*	128.5M	Q2 FY26 10-QJun 30, 2026
Lineage	58	1,361	311*	227.7M	Q2 FY26 10-QJun 30, 2026
Tanger	177	156	93*	114.9M	Q2 FY26 10-QJun 30, 2026
Rayonier	412	396	not reported	297.6M	Q2 FY26 10-QJun 30, 2026
Broadstone Net Lease	12	122	88*	192.0M	Q3 FY26 10-QSep 30, 2026
Dolby Laboratories	669	305	167*	not reported	Q3 FY26 10-QJun 26, 2026
National Health Investors	30	121	65*	49.1M	Q2 FY26 10-QJun 30, 2026

Not investment advice. Not affiliated with the U.S. SEC.